Medicine Supply Notification: Triamterene 50mg / furosemide 40mg (Frusene® ) tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamterene 50mg / furosemide 40mg (Frusene® ) tablets.
MSN/2022/033
Tier 2 – medium impact
Date of issue 13th April 2022
- Triamterene 50mg/furosemide 40mg (Frusene®) tablets have been discontinued and all remaining stocks have been exhausted.
- Co-amilofruse 5mg/40mg tablets remain available and can support a full uplift in demand.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
